Autolus Therapeutics Ltd reported $266.14M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 44K Jun/2026
Autolus Therapeutics Ltd USD 266.14M 0 Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Novartis USD 1.9B 7.38M Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Silence Therapeutics USD 141.7M 0 Dec/2025